Cart
sales@molnova.com
Denosumab
CAS No. 615258-40-7
Denosumab ( —— )
Catalog No. M22148 CAS No. 615258-40-7
Denosumab is a monoclonal antibody given subcutaneously that inhibits osteoclast activity by targeting the RANK ligand.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 483 | In Stock |
|
| 10MG | 698 | In Stock |
|
| 25MG | 1071 | In Stock |
|
| 50MG | 1431 | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameDenosumab
-
NoteResearch use only, not for human use.
-
Brief DescriptionDenosumab is a monoclonal antibody given subcutaneously that inhibits osteoclast activity by targeting the RANK ligand.
-
DescriptionDenosumab is a monoclonal antibody given subcutaneously that inhibits osteoclast activity by targeting the RANK ligand.
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorOther Targets
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number615258-40-7
-
Formula Weight147 kDa
-
Molecular Formula——
-
Purity>98% (HPLC)
-
Solubility——
-
SMILES——
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Kuritani M, et al. Anti-mouse RANKL Antibodies Inhibit Alveolar Bone Destruction in Periodontitis Model Mice. Biol Pharm Bull.2018;41(4):637-643.
molnova catalog
related products
-
Mycophenolate Mofeti...
Mycophenolate Mofetil(RS 61443) is a non-competitive, selective and reversible inhibitor of inosine monophosphate dehydrogenase I/II with IC50 of 39 nM and 27 nM, respectively.
-
Sibiricose A4
Sibiricose A4 is a natural product for research related to life sciences.
-
Saikosaponin B4
Saikosaponin B4 is isolated from the MeOH extract of the roots of Bupleurum falcatum L.
